MAVERIC: Midlands trial of amiodarone vs electrophysiology-guided interventions and cardio-defibrillator in ventricular arrhythmias.
ISRCTN | ISRCTN14274472 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN14274472 |
Secondary identifying numbers | ID6 |
- Submission date
- 23/01/2004
- Registration date
- 23/01/2004
- Last edited
- 21/12/2009
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Michael Griffith
Scientific
Scientific
Department of Cardiology
Queen Elizabeth Hospital
Edgbaston
Birmingham
B15 2TH
United Kingdom
Phone | +44 (0)121 627 2043 |
---|
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Not Specified |
Scientific title | |
Study acronym | MAVERIC |
Study objectives | The optimal way to manage patients who present with sustained ventricular tachycardia (VT), ventricular fibrillation (VF) or sudden cardiac death (SCD), especially in the context of comparing the traditional approach of empirical amiodarone against electrophysiology-guided interventions, which include myocardial revsacularisation, programmed ventricular stimulation and the implantable cardioverter-defibrillator (ICD). |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Cardiovascular diseases: Heart disease |
Intervention | Electrophysiology + implantable cardioverter defibrillators (ICDs) versus Amiodarone empirically |
Intervention type | Other |
Primary outcome measure | 1. Death 2. Arrhythmia recurrence 3. Hospitalisation 4. Drug use 5. Quality of life 6. Cost of managing patients |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/11/1996 |
Completion date | 30/11/1999 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | 214 (Added 19/11/09) |
Key inclusion criteria | 1. Patients who presented with sustained ventricular tachycardia (VT), ventricular fibrillation (VF) or sudden cardiac death (SCD) and survived to reach hospital within the Midlands from Feb 1997 to Jan 1999 were actively identified and entered into the study. 2. Patients who were not of child-bearing age or had a life-expectancy of <6 months from a non-arrhythmic cause were approached for entry into the trial. Patients who were ineligible for or refused to join the trial were entered into the study's registry. |
Key exclusion criteria | Does not match inclusion criteria |
Date of first enrolment | 01/11/1996 |
Date of final enrolment | 30/11/1999 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Department of Cardiology
Birmingham
B15 2TH
United Kingdom
B15 2TH
United Kingdom
Sponsor information
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Government
Government
The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Website | http://www.doh.gov.uk |
---|
Funders
Funder type
Government
NHS Cardiovascular Disease and Stroke National Research and Development Programme (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Protocol article | protocol | 01/07/1998 | Yes | No | |
Results article | results | 01/07/2004 | Yes | No |